Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency.

Nisii C, Vincenti D, Fusco FM, Schmidt-Chanasit J, Carbonnelle C, Raoul H, Eickmann M, Hewson R, Brave A, Nuncio S, Sanchez-Seco MP, Palyi B, Kis Z, Zange S, Nitsche A, Kurth A, Strasser M, Capobianchi MR, Ozin A, Guglielmetti P, Menel-Lemos C, Jacob D, Grunow R, Ippolito G, Di Caro A.

Clin Microbiol Infect. 2017 Feb;23(2):58-60. doi: 10.1016/j.cmi.2016.07.003. Epub 2016 Jul 9. No abstract available.

2.

Validating the Inactivation Effectiveness of Chemicals on Ebola Virus.

Haddock E, Feldmann F.

Methods Mol Biol. 2017;1628:251-257. doi: 10.1007/978-1-4939-7116-9_20.

PMID:
28573626
3.

European perspective of 2-person rule for biosafety level 4 laboratories.

Ippolito G, Nisii C, Di Caro A, Brown D, Gopal R, Hewson R, Lloyd G, Gunther S, Eickmann M, Mirazimi A, Koivula T, Georges Courbot MC, Raoul H, Capobianchi MR.

Emerg Infect Dis. 2009 Nov;15(11):1858. doi: 10.3201/eid1511.091134. No abstract available.

4.

Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic.

Zhang Y, Gong Y, Wang C, Liu W, Wang Z, Xia Z, Bu Z, Lu H, Sun Y, Zhang X, Cao Y, Yang F, Su H, Hu Y, Deng Y, Zhou B, Zhao Z, Fu Y, Kargbo D, Dafae F, Kargbo B, Kanu A, Liu L, Qian J, Guo Z.

PLoS Negl Trop Dis. 2017 May 15;11(5):e0005622. doi: 10.1371/journal.pntd.0005622. eCollection 2017 May.

5.

U.S. Ebola Treatment Center Clinical Laboratory Support.

Jelden KC, Iwen PC, Herstein JJ, Biddinger PD, Kraft CS, Saiman L, Smith PW, Hewlett AL, Gibbs SG, Lowe JJ.

J Clin Microbiol. 2016 Apr;54(4):1031-5. doi: 10.1128/JCM.02905-15. Epub 2016 Feb 3.

6.

Containment Care Units for Managing Patients With Highly Hazardous Infectious Diseases: A Concept Whose Time Has Come.

Kortepeter MG, Kwon EH, Hewlett AL, Smith PW, Cieslak TJ.

J Infect Dis. 2016 Oct 15;214(suppl 3):S137-S141. Epub 2016 Sep 19.

PMID:
27651413
7.

Pseudoparticle neutralization assay for detecting ebola- neutralizing antibodies in biosafety level 2 settings.

Chin AW, Perera RA, Guan Y, Halfmann P, Kawaoka Y, Peiris M, Poon LL.

Clin Chem. 2015 Jun;61(6):885-6. doi: 10.1373/clinchem.2015.238204. Epub 2015 Mar 31. No abstract available.

8.

Gleanings from the harvest: suggestions for priority actions against Ebola virus epidemics.

Johnson KM.

J Infect Dis. 1999 Feb;179 Suppl 1:S287-8. No abstract available.

PMID:
9988198
9.

Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients.

Tempestilli M, Pucci L, Notari S, Di Caro A, Castilletti C, Rivelli MR, Agrati C, Pucillo LP.

Clin Chem Lab Med. 2015 Nov;53(12):1967-73. doi: 10.1515/cclm-2015-0119.

PMID:
26053010
10.

Ebola virus disease: Biological and diagnostic evolution from 2014 to 2017.

Mérens A, Bigaillon C, Delaune D.

Med Mal Infect. 2018 Mar;48(2):83-94. doi: 10.1016/j.medmal.2017.11.002. Epub 2017 Dec 8. Review.

PMID:
29224715
11.

Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory.

Alimonti J, Leung A, Jones S, Gren J, Qiu X, Fernando L, Balcewich B, Wong G, Ströher U, Grolla A, Strong J, Kobinger G.

Sci Rep. 2014 Jul 25;4:5824. doi: 10.1038/srep05824.

12.

Biosafety standards for working with Crimean-Congo hemorrhagic fever virus.

Weidmann M, Avsic-Zupanc T, Bino S, Bouloy M, Burt F, Chinikar S, Christova I, Dedushaj I, El-Sanousi A, Elaldi N, Hewson R, Hufert FT, Humolli I, Jansen van Vuren P, Koçak Tufan Z, Korukluoglu G, Lyssen P, Mirazimi A, Neyts J, Niedrig M, Ozkul A, Papa A, Paweska J, Sall AA, Schmaljohn CS, Swanepoel R, Uyar Y, Weber F, Zeller H.

J Gen Virol. 2016 Nov;97(11):2799-2808. doi: 10.1099/jgv.0.000610. Epub 2016 Sep 19.

PMID:
27667586
13.

[Mobile laboratories for rapid deployment and their contribution to the containment of emerging diseases in Sub-Saharan Africa, illustrated by the example of Ebola virus disease].

Diers J, Kouriba B, Ladan Fofana L, Fleischmann E, Starke M, Diallo S, Babin FX, von Bonin J, Wölfel R.

Med Sante Trop. 2015 Jul-Sep;25(3):229-33. doi: 10.1684/mst.2015.0485. French.

14.

Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Kimman TG, Smit E, Klein MR.

Clin Microbiol Rev. 2008 Jul;21(3):403-25. doi: 10.1128/CMR.00014-08. Review.

15.

Strategies for containing Ebola in West Africa.

Pandey A, Atkins KE, Medlock J, Wenzel N, Townsend JP, Childs JE, Nyenswah TG, Ndeffo-Mbah ML, Galvani AP.

Science. 2014 Nov 21;346(6212):991-5. doi: 10.1126/science.1260612. Epub 2014 Oct 30.

16.

Development and use of mobile containment units for the evaluation and treatment of potential Ebola virus disease patients in a United States hospital.

Sugalski G, Murano T, Fox A, Rosania A.

Acad Emerg Med. 2015 May;22(5):616-22. doi: 10.1111/acem.12664. Epub 2015 Apr 21.

17.

["Ebola: a major humanitarian crisis that may linger" (Pr Peter Piot)].

Piot P, Nau JY.

Rev Med Suisse. 2014 Oct 8;10(445):1892-3. French. No abstract available.

PMID:
25417363
18.

Good laboratory practices guarantee biosafety in the Sierra Leone-China friendship biosafety laboratory.

Wang Q, Zhou WM, Zhang Y, Wang HY, Du HJ, Nie K, Song JD, Xiao K, Lei WW, Guo JQ, Wei HJ, Cai K, Wang YH, Wu J, Kamara G, Kamara I, Wei Q, Liang MF, Wu GZ, Dong XP.

Infect Dis Poverty. 2016 Jun 23;5(1):62. doi: 10.1186/s40249-016-0154-5.

19.

Smart Card Decontamination in a High-Containment Laboratory.

Gabbert LR, Smith JD, Neilan JG, Ferman GS, Rasmussen MV.

Health Secur. 2018 Jul/Aug;16(4):244-251. doi: 10.1089/hs.2018.0023. Epub 2018 Aug 10.

20.

Ebola and Its Control in Liberia, 2014-2015.

Nyenswah TG, Kateh F, Bawo L, Massaquoi M, Gbanyan M, Fallah M, Nagbe TK, Karsor KK, Wesseh CS, Sieh S, Gasasira A, Graaff P, Hensley L, Rosling H, Lo T, Pillai SK, Gupta N, Montgomery JM, Ransom RL, Williams D, Laney AS, Lindblade KA, Slutsker L, Telfer JL, Christie A, Mahoney F, De Cock KM.

Emerg Infect Dis. 2016 Feb;22(2):169-77. doi: 10.3201/eid2202.151456.

Supplemental Content

Support Center